MF
Elite in Nelson Syndrome

Dr. Maria Fleseriu

OHSU Primary Care Clinic At South Waterfront
Portland, OR
Elite
 in Nelson Syndrome
Specialties:Endocrinology
Experience:30 Years
Accepts:New PatientsMedicare
About|Expertise|Insurance|Location|Research
Areas of Expertise

Many doctors have expertise treating multiple conditions. MediFind uses a variety of data sources to determine what conditions a doctor treats and their level of experience.

Check Dr. Maria Fleseriu's experience treating your condition:
About Dr. Maria Fleseriu

Maria Fleseriu is an Endocrinologist in Portland, Oregon. Fleseriu has been practicing medicine for over 30 years and is rated as an Elite expert by MediFind in the treatment of Nelson Syndrome. She is also highly rated in 23 other conditions, according to our data. Her top areas of expertise are Acromegaly, Cushing Disease, Pituitary Tumor, Acromegaloid Facial Appearance Syndrome, and Hormone Replacement Therapy (HRT). She is licensed to treat patients in Oregon. Fleseriu is currently accepting new patients.

Her clinical research consists of co-authoring 186 peer reviewed articles and participating in 7 clinical trials in the past 15 years. In particular, she has co-authored 11 articles and participated in 3 clinical trials in the study of Nelson Syndrome.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Maria Fleseriu it is best to call her office and ask if your insurance is accepted.

Accepts Medicare
Call to see if your plan is accepted.
Locations
3303 Sw Bond Ave, Portland, OR 97239
Background & Education
Graduate Institution
Other, 1993
Specialties
Endocrinology
Licenses
Internal Medicine in OR
Hospital Affiliations
Samaritan Albany General Hospital
Mid-Columbia Medical Center
St Charles Redmond
Sky Lakes Medical Center
Good Samaritan Regional Medical Center
OHSU Hospital - Portland
Providence Hood River Memorial Hospital
Languages Spoken
English
Gender
Female
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials
A Double-blind, Placebo-Controlled, Randomized Withdrawal Following Open Label Therapy Study to Assess the Safety and Efficacy of Levoketoconazole (2S, 4R-ketoconazole) in the Treatment of Endogenous Cushing's Syndrome
Enrollment Status: Completed
Publish Date: November 08, 2022
Intervention Type: Drug
Study Phase: Phase 3
An Open-label, Multi-center, Roll-over Study to Assess Long Term Safety in Patients With Endogenous Cushing's Syndrome Who Have Completed a Prior Novartis-sponsored Osilodrostat (LCI699) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Osilodrostat
Enrollment Status: Active, not recruiting
Publish Date: May 06, 2022
Intervention Type: Drug
Study Drug: Osilodrostat
Study Phase: Phase 2
A Phase III, Multi-center, Randomized, Double-blind, 48 Week Study With an Initial 12 Week Placebo-controlled Period to Evaluate the Safety and Efficacy of Osilodrostat in Patients With Cushing's Disease
Enrollment Status: Completed
Publish Date: November 01, 2021
Intervention Type: Drug
Study Phase: Phase 3
An Open-label Extension Study of Levoketoconazole (2S,4R-ketoconazole) in the Treatment of Endogenous Cushing's Syndrome
Enrollment Status: Active, not recruiting
Publish Date: August 03, 2021
Intervention Type: Drug
Study Drug: Levoketoconazole
Study Phase: Phase 3
An Open Label Study to Assess the Safety and Efficacy of COR-003 (Levoketoconazole) in the Treatment of Endogenous Cushing's Syndrome
Enrollment Status: Completed
Publish Date: April 19, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of ATR-101 for the Treatment of Cushing's Syndrome
Enrollment Status: Terminated
Publish Date: March 02, 2021
Intervention Type: Drug
Study Phase: Phase 2
Phase III, Multi-center, Double-blind, Randomized Withdrawal Study of LCI699 Following a 24 Week, Single-arm, Open-label Dose Titration and Treatment Period to Evaluate the Safety and Efficacy of LCI699 for the Treatment of Patients With Cushing's Disease
Enrollment Status: Completed
Publish Date: January 06, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 6 Less Clinical Trials -
186 Total Publications
Long-term efficacy and safety of osilodrostat in Cushing's disease: final results from a Phase II study with an optional extension phase (LINC 2).
Journal: Pituitary
Published: September 23, 2022
Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
WL
Dr. Winnie Y. Liu
Endocrinology
Experienced
Highly rated in
0
conditions
Endocrinology

OHSU

Oregon Health And Sciences University/university Medical Group

3181 Sw Sam Jackson Park Rd, 
Portland, OR 
 0.8 mi

Winnie Liu is an Endocrinologist in Portland, Oregon. Liu has been practicing medicine for over 10 years and is rated as an Experienced expert by MediFind in the treatment of Nelson Syndrome. Her top areas of expertise are Thyroid Storm, Nelson Syndrome, Hypercalcemia, and Familial Hypocalciuric Hypercalcemia Type 1. She is licensed to treat patients in Colorado and Oregon. Liu is currently accepting new patients.

RZ
Dr. Roula S. Zahr
Endocrinology
Experienced
Highly rated in
4
conditions
Endocrinology

OHSU

OHSU Harold Schnitzer Diabetes Health Center And Endocrinology Clinic, Marquam Hill

3270 Sw Pavilion Loop, 
Portland, OR 
 0.7 mi

Roula Zahr is an Endocrinologist in Portland, Oregon. Zahr has been practicing medicine for over 17 years and is rated as an Advanced expert by MediFind in the treatment of Nelson Syndrome. She is also highly rated in 4 other conditions, according to our data. Her top areas of expertise are Triple A Syndrome, Type 1 Diabetes (T1D), Secondary Adrenal Insufficiency, and Addison's Disease. She is licensed to treat patients in Oregon, Pennsylvania, and Iowa. Zahr is currently accepting new patients.

EM
Dr. Ekaterina A. Manuylova
Endocrinology
Experienced
Highly rated in
1
conditions
Endocrinology

Salem Health

Firehouse Diabetes And Endocrine Center

1585 Liberty St Se, 
Salem, OR 
 43.6 mi

Ekaterina Manuylova is an Endocrinologist in Salem, Oregon. Manuylova has been practicing medicine for over 18 years and is rated as an Advanced expert by MediFind in the treatment of Nelson Syndrome. She is also highly rated in 1 other condition, according to our data. Her top areas of expertise are Cushing Disease, Cushing Syndrome, Pituitary Tumor, and Hypothalamic Tumor. She is licensed to treat patients in New York. Manuylova is currently accepting new patients.